SAT-161 - Obeticholic acid, a FXR agonist, inhibits the cancerogenic potential of primary human cholangiocarcinoma (CCA) cells cultures

Autor: Matteo, S.D., Nevi, L., Constantini, D., Colantonio, M., Giulitti, F., Napoletano, C., Safarikia, S., Manzi, E., Rose, A.M.D., Melandro, F., Bragazzi, M., Berloco, P.B., Giuliante, F., Carpino, G., Cardinale, V., Gaudio, E., Alvaro, D.
Zdroj: In Journal of Hepatology April 2018 68 Supplement 1:S677-S679
Databáze: ScienceDirect